[8-K] Acco Brands Corporation Reports Material Event

Rhea-AI Filing Summary

On 31 Jul 2025 The Clorox Company (NYSE: CLX) filed a Form 8-K to furnish its fiscal Q4 and full-year 2025 results under Item 2.02 and to provide supplemental information under Item 7.01. While the filing references the earnings press release (Exhibit 99.1) and detailed schedules (Exhibit 99.2), no quantitative data (revenue, EPS, margin, guidance) are included in the body of the report itself; investors must review the exhibits for specifics.

No other corporate events—such as acquisitions, restructurings, capital actions or leadership changes—are disclosed. The document’s primary purpose is to place the earnings materials into the public domain and satisfy SEC disclosure requirements; market impact therefore depends entirely on the financial figures contained in the attached exhibits, not on the 8-K narrative.

Insights

Sell-Side Equity Analyst

TL;DR: Procedural 8-K—earnings exhibits attached, no numbers inside; impact depends on figures not shown here.

Because the core financial metrics are only embedded in Exhibits 99.1 and 99.2, the filing itself offers no basis to revise estimates or valuation. Investors must consult the press release to assess sales trends, margins, pricing or FY26 guidance. From a trading perspective, the 8-K per se is neutral; price reaction will hinge on the separate earnings data.

Corporate Governance Specialist

TL;DR: Standard compliance filing; demonstrates timely disclosure, no governance red flags detected.

Clorox met its reporting obligations by promptly furnishing the earnings release via Form 8-K. Inclusion of supplemental schedules improves transparency. There are no indications of restatements, internal-control issues, or unusual board actions. Accordingly, governance risk remains unchanged and impact is minimal.

false000071203400007120342025-07-292025-07-29

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 29, 2025

ACCO Brands Corporation

(Exact name of registrant as specified in its charter)

____________________________

Delaware	001-08454	36-2704017
(State or other jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

Four Corporate Drive

Lake Zurich, Illinois 60047

(Address of Registrant’s Principal Executive Office, Including Zip Code)

Registrant's telephone number, including area code: (847) 541-9500

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8‑K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a‑12 under the Exchange Act (17 CFR 240.14a‑12)

☐ Pre-commencement communications pursuant to Rule 14d‑2(b) under the Exchange Act (17 CFR 240.14d‑2(b))

☐ Pre-commencement communications pursuant to Rule 13e‑4(c) under the Exchange Act (17 CFR 240.13e‑4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	ACCO	NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Section 1 - Registrant's Business and Operations

Item 1.01. Entry into a Material Definitive Agreement

Effective July 29, 2025, ACCO Brands Corporation (the “Company”) entered into an Eighth Amendment (the “Eighth Amendment”) to its Third Amended and Restated Credit Agreement, as amended (the “Credit Agreement”), among the Company, certain subsidiaries of the Company, Bank of America, N.A., as administrative agent, and the other lenders party thereto. Pursuant to the Eighth Amendment, the Credit Agreement was amended to, among other things:

•increase the maximum consolidated leverage ratio financial covenant (i) to 4.50x for the fiscal quarters ending September 30, 2025 and December 31, 2025; (ii) to 4.75x for the fiscal quarters ending March 31, 2026 and June 30, 2026; and (iii) to 4.25x for the fiscal quarters ending September 30, 2026 and December 31, 2026;

•modify through December 31, 2026 certain covenant baskets related to liens, indebtedness and restricted payments; and

•provide that $35 million in outstanding principal amount under the term loan facility will be repaid on or before September 30, 2025.

The foregoing summary of the Eighth Amendment does not purport to be complete and is qualified in its entirety by reference to the Eighth Amendment, a copy of which is filed as Exhibit 10.1 and incorporated by reference herein.

Section 2 - Financial Information

Item 2.02. Results of Operations and Financial Condition

On July 31, 2025, ACCO Brands Corporation (the "Company") announced its results for the period ended June 30, 2025. Attached as Exhibit 99.1 is a copy of the press release relating to the Company's results, which is incorporated herein by reference.

The information included or incorporated by reference in this Current Report on Form 8-K under this Item 2.02 is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Section 9 - Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

10.1		Eighth Amendment to Third Amended and Restated Credit Agreement, dated July 29, 2025, among the Company, certain subsidiaries of the Company, Bank of America, N.A. as administrative agent, and the other lenders party thereto.
99.1		Press release of the Company announcing results for the period ended June 30, 2025.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		ACCO Brands Corporation (Registrant)
Date:	July 31, 2025	By:	/s/ Deborah A. O'Connor
			Name: Deborah A. O'Connor
			Title: Executive Vice President
			and Chief Financial Officer

FAQ

When did Clorox (CLX) file its latest Form 8-K?

The company filed the Form 8-K on July 31, 2025.

What items are covered in Clorox’s July 31 2025 Form 8-K?

The filing covers Item 2.02 (Results of Operations) and Item 7.01 (Regulation FD disclosure).

Where can investors find Clorox’s Q4 FY25 financial figures?

Detailed numbers are in Exhibit 99.1 (press release) and Exhibit 99.2 (supplemental tables) attached to the 8-K.

Did the 8-K report any mergers, leadership changes or legal issues?

No. The document only furnishes earnings information; it reports no other material corporate events.